Clinical Trials Logo

Clinical Trial Summary

Since its introduction in 1973, etomidate has been widely used in clinical anaesthesia, especially in haemodynamically unstable patients, as a new anaesthetic induction drug with the advantage of low circulatory and respiratory depression. When administered via intravenous injection, etomidate can cause adverse effects such as injection pain and myoclonus. The incidence of myoclonus is still reported to be as high as 50-80%. Myoclonus caused by etomidate may cause discomfort during induction of anaesthesia and reduce perioperative satisfaction, and may lead to syringe dislodgement, extravasation of the injected drug, swelling at the injection site, delayed induction of anaesthesia and, in severe cases, cardiovascular adverse events. Therefore, the myoclonus and limb retraction reactions caused by etomidate are a key concern for clinical anaesthesiologists and need to be addressed at a time when comfort anaesthesia is being promoted. The aim of this study was to reduce myoclonus produced by etomidate injection during induction of general anaesthesia in surgical patients and to investigate the half effective dose of remifentanil to reduce etomidate myoclonus.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05754762
Study type Interventional
Source Yangzhou University
Contact
Status Not yet recruiting
Phase N/A
Start date March 1, 2023
Completion date July 1, 2023

See also
  Status Clinical Trial Phase
Not yet recruiting NCT02518789 - Effects and Mechanism of Pretreatment With Dexmedetomidine to Etomidate Induce Myoclonus Phase 4
Completed NCT04235452 - Electrophysiological Characteristics and Anatomical Differentiation of Epileptic and Non-epileptic Myoclonus.
Completed NCT00001667 - Genotype/Phenotype Correlation of Movement Disorders and Other Neurological Diseases N/A
Completed NCT00244361 - Effectiveness of Rituximab in Pediatric OMS Patients. Phase 1/Phase 2
Recruiting NCT05317390 - Clinical Validation of DystoniaNet Deep Learning Platform for Diagnosis of Isolated Dystonia N/A
Completed NCT00001663 - Treatment of Cortical Myoclonus With Repetitive Transcranial Magnetic Stimulation Phase 1
Recruiting NCT00029965 - Natural History of Glycosphingolipid Storage Disorders and Glycoprotein Disorders
Terminated NCT00506012 - Pilot Efficacy Study of T2000 in Myoclonus Dystonia Phase 2